Use access key #2 to skip to page content.
$5.23 0.09 (1.75%)
5/16/2008 4:00 PM

Stereotaxis, Inc. (STXS)

CAPS Rating:
**

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

View Ticker Page (STXS)

Results 1 - 10 of 18 :   12

Recs

5

Avatar joel415 (89.80) Submitted: 8/03/07 10:40 AM : Outperform Start Price: $12.00 STXS Score: -49.51

It looks like the days of doctors manually trying to push tubes around the body in the cath lab are almost over. Both STXS and HNSN make systems that are essentially disruptive technologies. They enable cariologist to deal with tougher cases, quicker...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar pvfund (< 20) Submitted: 9/25/07 1:45 PM : Outperform Start Price: $12.91 STXS Score: -53.75

STXS has FDA approval to perform the actual procedures in EP, AF and has a competitive advantage over its rival HNSN because 66 systems have been installed and 10000 procedures have been performed with glowing results. Revs are lumpy as installation ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar jimandjo4 (< 20) Submitted: 8/23/06 3:22 PM : Outperform Start Price: $11.16 STXS Score: -62.86

They sell a device which has no real competition.
Problem is, the medical device is very expensive.
They seem to have turned things around, and are making progress. This stock is not for the faint hearted, but could have a one hundred percent increa...

Report this Post Replies: 2 | Reply | Permalink

Recs

1

Avatar agoodtoy (< 20) Submitted: 5/17/07 4:18 PM : Outperform Start Price: $11.47 STXS Score: -48.25

Medical Device maker, leader in it's field. Stereotaxis Niobe System is a cardiology instrument control system for the interventional treatment of coronary artery disease and arrhythmias in the United States, Europe. Cath Labs are getting more and ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar alolio (< 20) Submitted: 10/24/06 12:09 AM : Outperform Start Price: $12.10 STXS Score: -60.97

The technology that Stereotaxis employs is excellent, revolutionary even, and if they can keep up with the pace of technology that they have set there is excellent potential for this company to do well. On the down side, it is a very expensive piece...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar rossoyoungs (< 20) Submitted: 2/25/07 11:17 PM : Outperform Start Price: $12.31 STXS Score: -55.34

Dr. jekyll, Mr. Hyde, bounces like a ball - market cap high but trend says it will win, I would buy at 10 and watch for insiders to sell at 11.50 (idiots should stop killing the upside. could go much higher in several years.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar MarkWayne1969 (< 20) Submitted: 5/06/08 11:37 PM : Outperform Start Price: $5.61 STXS Score: -7.27

Sound science. Methodology good. Large and sustained venture cap investment. Look for 2-4 multiplier in this time frame.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar daddies999 (48.45) Submitted: 4/04/08 2:03 AM : Outperform Start Price: $7.41 STXS Score: -32.95

Impressive non-invasive technology.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar mrsudbury (83.46) Submitted: 2/15/08 9:49 PM : Outperform Start Price: $6.77 STXS Score: -27.11

Looks cheap at these levels

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar MacroAlan (88.53) Submitted: 11/19/07 9:42 AM : Outperform Start Price: $12.93 STXS Score: -57.92

Tops in their industry.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners